Portfolio Holdings Detail for ISIN IE00BF4RFH31
Stock Name / FundiShares MSCI World Small Cap UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares III Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300PZLRJB7M8H1057
ETF TickerWSML(USD) LSE
ETF TickerWLDS(GBP) LSE
ETF TickerIUSN(EUR) F
ETF TickerIUSN.DE(EUR) CXE
ETF TickerWLDS.LS(GBP) CXE
ETF TickerWSML.LS(USD) CXE
ETF TickerWSML.L(GBP) LSE
ETF TickerWLDS.L(GBP) LSE

Holdings detail for OMCL

Stock NameOmnicell Inc
TickerOMCL(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS68213N1090
LEI5493008RH0GTKHHPZI77

Show aggregate OMCL holdings

News associated with OMCL

Implied FYX Analyst Target Price: $122
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-15 07:18:24
Omnicell (NASDAQ:OMCL) & Fulgent Genetics (NASDAQ:FLGT) Head-To-Head Analysis
Omnicell (NASDAQ:OMCL – Get Free Report) and Fulgent Genetics (NASDAQ:FLGT – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings and profitability. Risk and Volatility Omnicell has a beta of […] - 2025-09-12 05:16:53
The Zacks Analyst Blog Highlights Butterfly Network, Omnicell, NVIDIA, Palantir and IBM
Butterfly Network and Omnicell stand out as top health-tech stocks benefiting from AI, machine learning, and quantum advancements in healthcare, alongside NVIDIA, Palantir, and IBM driving transformative innovations. - 2025-09-12 04:35:00
NVIDIA, AI & Quantum Leaders Drive Health Tech: 2 Stocks to Buy
Butterfly Network and Omnicell emerge as standout health tech stocks as AI and quantum breakthroughs reshape diagnostics and medication management. - 2025-09-11 16:00:00
Brokerages Set Omnicell, Inc. (NASDAQ:OMCL) PT at $46.71
Shares of Omnicell, Inc. (NASDAQ:OMCL – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the seven ratings firms that are currently covering the stock, MarketBeat reports. Three research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 1-year […] - 2025-09-08 03:08:52
Brokerages Set Omnicell, Inc. (NASDAQ:OMCL) PT at $45.33
Shares of Omnicell, Inc. (NASDAQ:OMCL – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the seven ratings firms that are presently covering the company, MarketBeat.com reports. Three research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 1 […] - 2025-08-14 03:07:13
Federated Hermes Inc. Sells 41,248 Shares of Omnicell, Inc. (NASDAQ:OMCL)
Federated Hermes Inc. decreased its stake in shares of Omnicell, Inc. (NASDAQ:OMCL – Free Report) by 5.2% in the first quarter, HoldingsChannel reports. The institutional investor owned 746,499 shares of the company’s stock after selling 41,248 shares during the period. Federated Hermes Inc.’s holdings in Omnicell were worth $26,098,000 at the end of the most […] - 2025-08-01 04:26:49
Head to Head Review: Omnicell (NASDAQ:OMCL) vs. Schrodinger (NASDAQ:SDGR)
Omnicell (NASDAQ:OMCL – Get Free Report) and Schrodinger (NASDAQ:SDGR – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, dividends, analyst recommendations and valuation. Risk & Volatility Omnicell has a beta of 0.76, […] - 2025-08-01 02:50:53
Omnicell (NASDAQ:OMCL) Given New $40.00 Price Target at Wells Fargo & Company
Omnicell (NASDAQ:OMCL – Free Report) had its price objective boosted by Wells Fargo & Company from $37.00 to $40.00 in a research note released on Monday morning,Benzinga reports. The firm currently has an overweight rating on the stock. OMCL has been the topic of a number of other research reports. Piper Sandler reaffirmed an “overweight” […] - 2025-07-22 07:12:53
Principal Financial Group Inc. Has $8.55 Million Stake in Omnicell, Inc. (NASDAQ:OMCL)
Principal Financial Group Inc. boosted its position in shares of Omnicell, Inc. (NASDAQ:OMCL – Free Report) by 2.6% during the first quarter, HoldingsChannel reports. The institutional investor owned 244,644 shares of the company’s stock after purchasing an additional 6,288 shares during the period. Principal Financial Group Inc.’s holdings in Omnicell were worth $8,553,000 at the […] - 2025-07-15 05:04:22
Omnicell, Inc. (NASDAQ:OMCL) Receives $44.83 Consensus Target Price from Brokerages
Omnicell, Inc. (NASDAQ:OMCL – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the seven analysts that are presently covering the company, MarketBeat reports. Three research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12-month price objective among brokers […] - 2025-06-25 03:02:58
Omnicell, Inc. (NASDAQ:OMCL) Shares Sold by Exchange Traded Concepts LLC
Exchange Traded Concepts LLC lessened its position in shares of Omnicell, Inc. (NASDAQ:OMCL – Free Report) by 88.1% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 38,158 shares of the company’s stock after selling 281,524 shares during the quarter. Exchange Traded Concepts LLC’s holdings […] - 2025-06-19 04:58:57
Validea Kenneth Fisher Strategy Daily Upgrade Report - 6/18/2025
The following are today's upgrades for Validea's Price/Sales Investor model based on the published strategy of Kenneth Fisher. This value strategy rewards stocks with low P/S ratios, long-term profit growth, strong free cash flow and consistent profit margins.OMNICELL INC (OMCL) - 2025-06-18 06:30:33
Two Sigma Advisers LP Has $939,000 Holdings in Omnicell, Inc. (NASDAQ:OMCL)
Two Sigma Advisers LP trimmed its position in Omnicell, Inc. (NASDAQ:OMCL – Free Report) by 11.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 21,100 shares of the company’s stock after selling 2,600 shares during the period. Two Sigma Advisers LP’s holdings […] - 2025-06-02 06:56:50
Nuveen Asset Management LLC Trims Stock Position in Omnicell, Inc. (NASDAQ:OMCL)
Nuveen Asset Management LLC lessened its holdings in Omnicell, Inc. (NASDAQ:OMCL – Free Report) by 22.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 179,200 shares of the company’s stock after selling 50,790 shares during the period. Nuveen Asset Management LLC owned […] - 2025-05-29 04:56:59
Omnicell, Inc. (NASDAQ:OMCL) Receives Average Recommendation of “Moderate Buy” from Brokerages
Shares of Omnicell, Inc. (NASDAQ:OMCL – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the seven ratings firms that are presently covering the firm, MarketBeat.com reports. Three investment analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month price […] - 2025-05-28 02:34:49
Two Sigma Investments LP Boosts Stock Position in Omnicell, Inc. (NASDAQ:OMCL)
Two Sigma Investments LP increased its holdings in Omnicell, Inc. (NASDAQ:OMCL – Free Report) by 44.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 141,738 shares of the company’s stock after purchasing an additional 43,471 shares during the quarter. Two Sigma […] - 2025-05-27 05:28:55
Omnicell, Inc. (NASDAQ:OMCL) Shares Acquired by ProShare Advisors LLC
ProShare Advisors LLC boosted its stake in shares of Omnicell, Inc. (NASDAQ:OMCL – Free Report) by 44.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 13,766 shares of the company’s stock after buying an additional 4,238 shares during the quarter. ProShare Advisors […] - 2025-05-26 05:17:00
Omnicell (NASDAQ:OMCL) Price Target Raised to $34.00
Omnicell (NASDAQ:OMCL – Free Report) had its target price hoisted by Bank of America from $30.00 to $34.00 in a research report sent to investors on Friday morning,Benzinga reports. The firm currently has a neutral rating on the stock. OMCL has been the topic of a number of other research reports. JPMorgan Chase & Co. […] - 2025-05-26 02:58:50
Omnicell (NASDAQ:OMCL) Price Target Raised to $37.00
Omnicell (NASDAQ:OMCL – Free Report) had its target price upped by Wells Fargo & Company from $35.00 to $37.00 in a research note issued to investors on Friday morning,Benzinga reports. The brokerage currently has an overweight rating on the stock. Other equities research analysts have also issued research reports about the company. Benchmark dropped their […] - 2025-05-26 02:58:49
Northern Trust Corp Purchases 69,916 Shares of Omnicell, Inc. (NASDAQ:OMCL)
Northern Trust Corp raised its holdings in shares of Omnicell, Inc. (NASDAQ:OMCL – Free Report) by 14.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 565,026 shares of the company’s stock after acquiring an additional 69,916 shares during the period. Northern Trust Corp owned approximately 1.22% […] - 2025-05-12 04:48:57
Price T Rowe Associates Inc. MD Acquires 3,323 Shares of Omnicell, Inc. (NASDAQ:OMCL)
Price T Rowe Associates Inc. MD raised its holdings in shares of Omnicell, Inc. (NASDAQ:OMCL – Free Report) by 8.1% during the fourth quarter, HoldingsChannel reports. The fund owned 44,206 shares of the company’s stock after purchasing an additional 3,323 shares during the quarter. Price T Rowe Associates Inc. MD’s holdings in Omnicell were worth […] - 2025-05-08 04:58:56
Brokerages Set Omnicell, Inc. (NASDAQ:OMCL) Price Target at $50.67
Omnicell, Inc. (NASDAQ:OMCL – Get Free Report) has received a consensus recommendation of “Hold” from the six analysts that are covering the firm, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 1 year price target among brokers […] - 2025-05-06 03:07:10
Omnicell (NASDAQ:OMCL) Downgraded by StockNews.com to “Hold”
Omnicell (NASDAQ:OMCL – Get Free Report) was downgraded by research analysts at StockNews.com from a “buy” rating to a “hold” rating in a report issued on Saturday. A number of other brokerages have also recently issued reports on OMCL. Wells Fargo & Company dropped their target price on shares of Omnicell from $40.00 to $38.00 […] - 2025-05-05 02:30:43
Omnicell, Inc. (NASDAQ:OMCL) Shares Sold by Marshall Wace LLP
Marshall Wace LLP decreased its position in Omnicell, Inc. (NASDAQ:OMCL – Free Report) by 93.1% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 18,029 shares of the company’s stock after selling 245,023 shares during the period. Marshall Wace LLP’s holdings in Omnicell were worth […] - 2025-05-01 04:51:00
Omnicell, Inc. (NASDAQ:OMCL) Shares Sold by Envestnet Asset Management Inc.
Envestnet Asset Management Inc. cut its stake in shares of Omnicell, Inc. (NASDAQ:OMCL – Free Report) by 8.5% during the fourth quarter, Holdings Channel reports. The firm owned 86,070 shares of the company’s stock after selling 7,990 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Omnicell were worth $3,832,000 at the end of […] - 2025-04-24 04:26:47
Walleye Trading LLC Purchases Shares of 7,053 Omnicell, Inc. (NASDAQ:OMCL)
Walleye Trading LLC acquired a new position in shares of Omnicell, Inc. (NASDAQ:OMCL – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 7,053 shares of the company’s stock, valued at approximately $314,000. Several other hedge funds also recently modified their […] - 2025-04-21 06:20:53
Omnicell, Inc. (NASDAQ:OMCL) Shares Sold by Russell Investments Group Ltd.
Russell Investments Group Ltd. lessened its stake in shares of Omnicell, Inc. (NASDAQ:OMCL – Free Report) by 6.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 105,097 shares of the company’s stock after selling 7,643 shares during the quarter. Russell Investments Group Ltd. […] - 2025-04-15 04:54:50
120,670 Shares in Omnicell, Inc. (NASDAQ:OMCL) Bought by Arrowstreet Capital Limited Partnership
Arrowstreet Capital Limited Partnership acquired a new position in shares of Omnicell, Inc. (NASDAQ:OMCL – Free Report) during the fourth quarter, HoldingsChannel reports. The institutional investor acquired 120,670 shares of the company’s stock, valued at approximately $5,372,000. Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Vanguard […] - 2025-04-08 05:07:00
Mitsubishi UFJ Asset Management Co. Ltd. Cuts Position in Omnicell, Inc. (NASDAQ:OMCL)
Mitsubishi UFJ Asset Management Co. Ltd. lowered its holdings in shares of Omnicell, Inc. (NASDAQ:OMCL – Free Report) by 25.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 15,136 shares of the company’s stock after selling 5,069 shares during the quarter. Mitsubishi UFJ […] - 2025-04-03 04:44:56

iShares MSCI World Small Cap UCITS ETF USD (Acc) OMCL holdings

DateNumber of OMCL Shares HeldBase Market Value of OMCL SharesLocal Market Value of OMCL SharesChange in OMCL Shares HeldChange in OMCL Base ValueCurrent Price per OMCL Share HeldPrevious Price per OMCL Share Held
2025-10-15 (Wednesday)35,963USD 1,076,013USD 1,076,013
2025-10-10 (Friday)35,741USD 1,062,223USD 1,062,223
2025-10-08 (Wednesday)35,741USD 1,124,054USD 1,124,054
2025-10-07 (Tuesday)35,741OMCL holding increased by 148USD 1,081,165OMCL holding decreased by -5133USD 1,081,165148USD -5,133 USD 30.25 USD 30.52
2025-10-06 (Monday)35,593USD 1,086,298OMCL holding decreased by -15305USD 1,086,2980USD -15,305 USD 30.52 USD 30.95
2025-10-03 (Friday)35,593USD 1,101,603OMCL holding increased by 34525USD 1,101,6030USD 34,525 USD 30.95 USD 29.98
2025-10-02 (Thursday)35,593USD 1,067,078OMCL holding increased by 712USD 1,067,0780USD 712 USD 29.98 USD 29.96
2025-10-01 (Wednesday)35,593USD 1,066,366OMCL holding decreased by -17441USD 1,066,3660USD -17,441 USD 29.96 USD 30.45
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of OMCL by Blackrock for IE00BF4RFH31

Show aggregate share trades of OMCL

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-10-07BUY148 30.250* 36.33
2025-09-08SELL-296 32.330* 36.60 Profit of 10,834 on sale
2025-08-15BUY148 31.690* 36.63
2025-08-07BUY444 31.030* 36.69
2025-07-29BUY148 29.615* 36.90
2025-07-14BUY296 27.570* 37.27
2025-06-30BUY296 29.400* 37.60
2025-06-25BUY444 28.740* 37.76
2025-06-20SELL-75 28.030* 37.94 Profit of 2,846 on sale
2025-06-12SELL-600 29.940* 38.30 Profit of 22,980 on sale
2025-06-02BUY225 30.200* 38.71
2025-05-28BUY150 29.370* 38.90
2025-05-14BUY75 28.730* 39.71
2025-05-13BUY150 28.000* 39.80
2025-05-07BUY222 24.630* 40.25
2025-04-28BUY74 30.840* 40.84
2025-04-16BUY962 30.950* 41.59
2025-04-14BUY148 31.610* 41.78
2025-04-08SELL-148 30.520* 42.18 Profit of 6,242 on sale
2025-04-04SELL-150 32.690* 42.37 Profit of 6,356 on sale
2025-03-28BUY740 35.010* 42.67
2025-03-12SELL-148 33.340* 43.88 Profit of 6,494 on sale
2025-03-04SELL-148 37.390* 44.32 Profit of 6,559 on sale
2025-02-26SELL-296 39.730* 44.62 Profit of 13,208 on sale
2025-02-13BUY74 40.225* 45.26
2025-02-12BUY296 40.490* 45.33
2025-01-27BUY74 44.350* 45.78
2025-01-23BUY74 43.170* 45.87
2024-12-09BUY2,664 47.100* 45.89
2024-12-04BUY148 45.910* 45.88
2024-12-03BUY222 46.900* 45.86
2024-11-19BUY444 42.410* 45.93
2024-11-18BUY148 46.050* 45.93
2024-11-12BUY292 48.890* 45.84
2024-11-11BUY73 48.860* 45.63
2024-11-11BUY73 48.860* 45.63
2024-11-07BUY365 52.460* 44.76
2024-11-07BUY365 52.460* 44.76
2024-10-23BUY146 39.930* 40.78
2024-10-23BUY146 39.930* 40.78
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of OMCL

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1984,3480167,46250.4%
2025-09-1877,4220487,98715.9%
2025-09-1749,202633193,63525.4%
2025-09-1663,4587,64997,08965.4%
2025-09-1581,9070133,57961.3%
2025-09-1278,3910160,46648.9%
2025-09-1172,75271158,56345.9%
2025-09-10119,2180186,20764.0%
2025-09-0957,5440122,92646.8%
2025-09-0882,91812128,63664.5%
2025-09-0573,3830118,72161.8%
2025-09-0469,1267,281132,03452.4%
2025-09-0398,8568161,55961.2%
2025-09-0285,4621,500157,59654.2%
2025-08-2984,2020129,96364.8%
2025-08-2862,6170103,76760.3%
2025-08-2747,38013111,45942.5%
2025-08-2685,2320151,16056.4%
2025-08-2583,5430135,22861.8%
2025-08-22103,4810411,51025.1%
2025-08-2194,4160243,45938.8%
2025-08-2080,8883172,92946.8%
2025-08-1981,5270232,79335.0%
2025-08-1861,0060170,92535.7%
2025-08-1563,08050194,80632.4%
2025-08-1472,2630324,03822.3%
2025-08-1338,7610188,30020.6%
2025-08-1248,5321178,62227.2%
2025-08-1159,2193,375181,57032.6%
2025-08-0858,793230226,98325.9%
2025-08-0779,6810121,72865.5%
2025-08-0675,3040128,02358.8%
2025-08-05102,333350156,78965.3%
2025-08-04127,3450194,90165.3%
2025-08-01148,8630216,89868.6%
2025-07-31224,84448352,48563.8%
2025-07-30192,1770378,06850.8%
2025-07-2993,9790228,11141.2%
2025-07-2863,3970209,72330.2%
2025-07-2595,37135,400150,96063.2%
2025-07-2490,96919,600167,84254.2%
2025-07-2339,2780127,21730.9%
2025-07-2239,8961,507132,46930.1%
2025-07-2168,4900260,80926.3%
2025-07-1842,9490184,18223.3%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.